journal
https://read.qxmd.com/read/39128855/natural-product-pharmacology-the-british-journal-of-pharmacology-perspective
#21
REVIEW
Xin Wang, Angelo A Izzo, Andreas Papapetropoulos, Steve P H Alexander, Miriam Cortese-Krott, Dave A Kendall, Kirill A Martemyanov, Claudio Mauro, Reynold A Panettieri, Hemal H Patel, Rainer Schulz, Barbara Stefanska, Gary J Stephens, Mauro M Teixeira, Nathalie Vergnolle, Péter Ferdinandy
Natural products (NPs) have long been used as a rich source of bioactive compounds for drug development. Recent technological advancements have revitalised natural products research as evidenced by increased publications in this field. In this editorial review, we highlight key points from the 2020 British Journal of Pharmacology (BJP) practical guide, which outlines standards for natural products research reports, and provide papers published in BJP between years 2020 to 2023 that demonstrate adherence to these guidelines...
August 11, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/39118388/the-protein-disulfide-isomerase-a3-and-osteopontin-axis-promotes-influenza-induced-lung-remodelling
#22
JOURNAL ARTICLE
Amit Kumar, Zoe F Mark, Morgan P Carbajal, Dhemerson Souza DeLima, Nicolas Chamberlain, Joseph Walzer, Mona Ruban, Ravishankar Chandrasekaran, Nirav Daphtary, Minara Aliyeva, Matthew E Poynter, Yvonne M W Janssen-Heininger, Jason H Bates, John F Alcorn, Clemente J Britto, Charles S Dela Cruz, Anil G Jegga, Vikas Anathy
BACKGROUND AND PURPOSE: Fibrotic lung remodelling after a respiratory viral infection represents a debilitating clinical sequela. Studying or managing viral-fibrotic sequela remains challenging, due to limited therapeutic options and lack of understanding of mechanisms. This study determined whether protein disulfide isomerase A3 (PDIA3) and secreted phosphoprotein 1 (SPP1), which are associated with pulmonary fibrosis, can promote influenza-induced lung fibrotic remodelling and whether inhibition of PDIA3 or SPP1 can resolve viral-mediated fibrotic remodelling...
August 8, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/39117589/targeting-the-tyrosine-kinase-src-in-endothelium-attenuates-inflammation-and-atherogenesis-induced-by-disturbed-flow
#23
JOURNAL ARTICLE
Huanyu Ding, Minchun Jiang, Andrew M Chan, Yin Xia, Ronald C W Ma, Xiaoqiang Yao, Li Wang, Yu Huang
BACKGROUND AND PURPOSE: Previous studies have shown that Src can regulate inflammation and tumour progression. However, the mechanisms by which Src regulates the inflammatory response of vascular endothelium and atherogenesis are currently poorly understood. This study aimed to investigate the role of Src in endothelial inflammation and atherogenesis, as well as the underlying mechanisms. EXPERIMENTAL APPROACH: Real-time quantitative PCR was used to measure the mRNA levels of inflammatory genes...
August 8, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/39096023/in-silico-and-biological-analyses-of-missense-variants-of-the-human-biliary-efflux-transporter-abcc2-effects-of-novel-rare-missense-variants
#24
JOURNAL ARTICLE
Charlotte Kölz, Fabienne Z Gaugaz, Niklas Handin, Elke Schaeffeler, Roman Tremmel, Stefan Winter, Kathrin Klein, Ulrich M Zanger, Per Artursson, Matthias Schwab, Anne T Nies
BACKGROUND AND PURPOSE: The ATP-dependent biliary efflux transporter ABCC2, also known as multidrug resistance protein 2 (MRP2), is essential for the cellular disposition and detoxification of various xenobiotics including drugs as well as endogenous metabolites. Common functionally relevant ABCC2 genetic variants significantly alter drug responses and contribute to side effects. The aim of this study was to determine functional consequences of rare variants identified in subjects with European ancestry using in silico tools and in vitro analyses...
August 2, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/39091175/impacts-of-exposure-to-and-subsequent-discontinuation-of-clozapine-on-tripartite-synaptic-transmission
#25
JOURNAL ARTICLE
Motohiro Okada, Kouji Fukuyama, Eishi Motomura
BACKGROUND AND PURPOSE: Clozapine is an effective antipsychotic for treatment-resistant schizophrenia, but its discontinuation leads to discontinuation syndrome/catatonia complicated by benzodiazepine-resistance and rhabdomyolysis. EXPERIMENTAL APPROACH: This study determined time-dependent effects of exposure and subsequent discontinuation of clozapine on expression of connexin43, 5-HT receptors, intracellular L-β-aminoisobutyrate (L-BAIBA) and 2nd-messengers and signalling of AMPK, PP2A and Akt in cultured astrocytes and rat frontal cortex...
August 2, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/39081110/blockade-of-ca-v-3-calcium-channels-and-induction-of-g-0-g-1-cell-cycle-arrest-in-colon-cancer-cells-by-gossypol
#26
JOURNAL ARTICLE
Osbaldo Lopez-Charcas, Oumnia Benouna, Roxane Lemoine, Margarita Jacaranda Rosendo-Pineda, Tonantzin Guadalupe Anguheven-Ledezma, Lizeth Sandoval-Vazquez, Martin Leonardo Gallegos-Gomez, Leticia Robles-Martinez, Zazil Herrera-Carrillo, Miguel Ramírez-Aragón, Ana Alfaro, Stéphanie Chadet, Fabio Ferro, Pierre Besson, Lin-Hua Jiang, Sadanandan E Velu, Agustín Guerrero-Hernandez, Sébastien Roger, Juan Carlos Gomora
BACKGROUND AND PURPOSE: Gastrointestinal tumours overexpress voltage-gated calcium (CaV 3) channels (CaV 3.1, 3.2 and 3.3). CaV 3 channels regulate cell growth and apoptosis colorectal cancer. Gossypol, a polyphenolic aldehyde found in the cotton plant, has anti-tumour properties and inhibits CaV 3 currents. A systematic study was performed on gossypol blocking mechanism on CaV 3 channels and its potential anticancer effects in colon cancer cells, which express CaV 3 isoforms. EXPERIMENTAL APPROACH: Transcripts for CaV 3 proteins were analysed in gastrointestinal cancers using public repositories and in human colorectal cancer cell lines HCT116, SW480 and SW620...
July 31, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/39075330/the-atypical-antipsychotics-lurasidone-and-olanzapine-exert-contrasting-effects-on-the-gut-microbiome-and-metabolic-function-of-rats
#27
JOURNAL ARTICLE
Srinivas Kamath, Alexander Hunter, Kate Collins, Anthony Wignall, Paul Joyce
BACKGROUND AND PURPOSE: Antipsychotics such as olanzapine are associated with significant metabolic dysfunction, attributed to gut microbiome dysbiosis. A recent notion that most psychotropics are detrimental to the gut microbiome has arisen from consistent findings of metabolic adverse effects. However, unlike olanzapine, the metabolic effects of lurasidone are conflicting. Thus, this study investigates the contrasting effects of olanzapine and lurasidone on the gut microbiome to explore the hypothesis of 'gut neutrality' for lurasidone exposure...
July 29, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/39072736/idh2-nadph-pathway-protects-against-acute-pancreatitis-via-suppressing-acinar-cell-ferroptosis
#28
JOURNAL ARTICLE
Qi Peng, Bin Li, Pengli Song, Ruiyan Wang, Jing Jiang, Xuerui Jin, Jie Shen, Jingpiao Bao, Jianbo Ni, Xiao Han, Guoyong Hu
BACKGROUND AND PURPOSE: Acute pancreatitis (AP) is associated with acinar cell death and inflammatory responses. Ferroptosis is characterized by an overwhelming lipid peroxidation downstream of metabolic dysfunction, in which NADPH-related redox systems have been recognized as the mainstay in ferroptosis control. Nevertheless, it remains unknown how ferroptosis is regulated in AP and whether we can target it to restrict AP development. EXPERIMENTAL APPROACH: Metabolomics were applied to explore changes in metabolic pathways in pancreatic acinar cells (PACs) in AP...
July 27, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/39044481/allosterism-in-the-adenosine-a-2a-and-cannabinoid-cb-2-heteromer
#29
JOURNAL ARTICLE
Claudia Llinas Del Torrent, Iu Raïch, Angel Gonzalez, Jaume Lillo, Nil Casajuana-Martin, Rafael Franco, Leonardo Pardo, Gemma Navarro
BACKGROUND AND PURPOSE: Allosterism is a regulatory mechanism for GPCRs that can be attained by ligand-binding or protein-protein interactions with another GPCR. We have studied the influence of the dimer interface on the allosteric properties of the A2A receptor and CB2 receptor heteromer. EXPERIMENTAL APPROACH: We have evaluated cAMP production, phosphorylation of signal-regulated kinases (pERK1/2), label-free dynamic mass redistribution, β-arrestin 2 recruitment and bimolecular fluorescence complementation assays in the absence and presence of synthetic peptides that disrupt the formation of the heteromer...
July 23, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/39030902/sca44-and-scar13-associated-grm1-mutations-affect-metabotropic-glutamate-receptor-1-function-through-distinct-mechanisms
#30
JOURNAL ARTICLE
Yuyang Wang, Ashwin Muraleetharan, Monica Langiu, Karen J Gregory, Shane D Hellyer
BACKGROUND AND PURPOSE: Metabotropic glutamate receptor 1 (mGlu1 ) is a promising therapeutic target for neurodegenerative CNS disorders including spinocerebellar ataxias (SCAs). Clinical reports have identified naturally-occurring mGlu1 mutations in rare SCA subtypes and linked symptoms to mGlu1 mutations. However, how mutations alter mGlu1 function remains unknown, as does amenability of receptor function to pharmacological rescue. Here, we explored SCA-associated mutation effects on mGlu1 cell surface expression, canonical signal transduction and allosteric ligand pharmacology...
July 19, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/39014975/sex-differences-in-the-effects-of-n-ethylpentylone-in-young-cd1-mice-insights-on-behaviour-thermoregulation-and-early-gene-expression
#31
JOURNAL ARTICLE
María Espinosa-Velasco, Adriana Castro-Zavala, Marina D Reguilón, Inés Gallego-Landin, Marina Bellot, Olga Rublinetska, Olga Valverde, Marta Rodríguez-Arias, Núria Nadal-Gratacós, Xavier Berzosa, Cristian Gómez-Canela, Marcel Lí Carbó, Jorge Camarasa, Elena Escubedo, Raúl López-Arnau, David Pubill
BACKGROUND AND PURPOSE: New psychoactive substances such as N-ethylpentylone (NEP) are continuously emerging in the illicit drug market, and knowledge of their effects and risks, which may vary between sexes, is scarce. Our present study compares some key effects of NEP in male and female mice. EXPERIMENTAL APPROACH: Psychostimulant, rewarding and reinforcing effects were investigated by tracking locomotor activity, conditioned place preference (CPP) paradigm and through a self-administration (SA) procedure, respectively, in CD1 mice...
July 16, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/39014887/ticagrelor-increases-its-own-potency-at-the-p2y-12-receptor-by-directly-changing-the-plasma-membrane-lipid-order-in-platelets
#32
JOURNAL ARTICLE
Kyrylo Pyrshev, Florentin Allemand, Vahideh Rabani, Semen Yesylevskyy, Siamak Davani, Christophe Ramseyer, Jennifer Lagoutte-Renosi
BACKGROUND AND PURPOSE: Although the amphiphilic nature of the widely used antithrombotic drug Ticagrelor is well known, it was never considered as a membranotropic agent capable of interacting with the lipid bilayer in a receptor-independent way. In this study, we investigated the influence of Ticagrelor on plasma membrane lipid order in platelets and if this modulates the potency of Ticagrelor at the P2Y12 receptor. EXPERIMENTAL APPROACH: We combined fluorescent in situ, in vitro and in silico approaches to probe the interactions between the plasma membrane of platelets and Ticagrelor...
July 16, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/39001568/cell-based-therapy-for-diabetic-cardiovascular-complications-prospects-and-challenges
#33
REVIEW
Jia-Peng Li, Meng-Meng Fu, Xiao-Xue Li, Ming Xu
Diabetes mellitus is a long-term metabolic condition characterized by high blood glucose levels. This disorder is closely associated with a range of complications affecting small and large blood vessels, including conditions like retinopathy, nephropathy and neuropathy, as well as ischaemic heart disease, peripheral vascular disease and cerebrovascular disease. These complications cause organ and tissue damage in an estimated 33% to 50% of individuals with diabetes. The management of these complications in patients with diabetes is confronted with significant clinical challenges...
July 12, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38992898/repurposing-cyclovirobuxine-d-as-a-novel-inhibitor-of-colorectal-cancer-progression-via-modulating-the-cct3-yap-axis
#34
JOURNAL ARTICLE
Yiman Liu, Lu Chen, Jinghui Wang, Xiaomei Bao, Jiayan Huang, Yuling Qiu, Tao Wang, Haiyang Yu
BACKGROUND AND PURPOSE: Colorectal cancer (CRC) ranks second in mortality worldwide and requires effective and affordable remedies. Cyclovirobuxine D (CVB-D) is the main effective component of Huangyangning tablet, an approved traditional patent medicine, which is mainly used for cardiovascular treatment. As a multibioactive natural compound, CVB-D possesses underlying anticancer activities. EXPERIMENTAL APPROACH: Cell viability and clone-forming ability were determined in human CRC lines...
July 11, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38986570/inhibition-of-dynamin-related-protein-1-filamin-interaction-improves-systemic-glucose-metabolism
#35
JOURNAL ARTICLE
Yuri Kato, Kohei Ariyoshi, Yasunobu Nohara, Naoya Matsunaga, Tsukasa Shimauchi, Naoya Shindo, Akiyuki Nishimura, Xinya Mi, Sang Geon Kim, Tomomi Ide, Eiji Kawanishi, Akio Ojida, Naoki Nakashima, Yasuo Mori, Motohiro Nishida
BACKGROUND AND PURPOSE: Maintaining mitochondrial quality is attracting attention as a new strategy to treat diabetes and diabetic complications. We previously reported that mitochondrial hyperfission by forming a protein complex between dynamin-related protein (Drp) 1 and filamin, mediates chronic heart failure and cilnidipine, initially developed as an L/N-type Ca2+ channel blocker, improves heart failure by inhibiting Drp1-filamin protein complex. We investigated whether cilnidipine improves hyperglycaemia of various diabetic mice models...
July 10, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38982742/adjunctive-therapy-with-an-oral-h-2-s-donor-provides-additional-therapeutic-benefit-beyond-sglt2-inhibition-in-cardiometabolic-heart-failure-with-preserved-ejection-fraction
#36
JOURNAL ARTICLE
Jake E Doiron, Huijing Xia, Xiaoman Yu, Alexandra R Nevins, Kyle B LaPenna, Thomas E Sharp, Traci T Goodchild, Timothy D Allerton, Mona Elgazzaz, Eric Lazartigues, Sanjiv J Shah, Zhen Li, David J Lefer
BACKGROUND AND PURPOSE: Sodium glucose cotransporter 2 inhibitors (SGLT2i) have emerged as a potent therapy for heart failure with preserved ejection fraction (HFpEF). Hydrogen sulphide (H2 S), a well-studied cardioprotective agent, could be beneficial in HFpEF. SGLT2i monotherapy and combination therapy involving an SGLT2i and H2 S donor in two preclinical models of cardiometabolic HFpEF was investigated. EXPERIMENTAL APPROACH: Nine-week-old C57BL/6N mice received L-NAME and a 60% high fat diet for five weeks...
July 9, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38982721/arbidol-an-antiviral-drug-identified-as-a-sodium-channel-blocker-with-anticonvulsant-activity
#37
JOURNAL ARTICLE
Min Li, Yuchen Jin, Jun Wu, Miao Zhao, Kexin Yu, Haibo Yu
BACKGROUND AND PURPOSE: Sodium channel blockers (SCBs) have traditionally been utilized as anti-seizure medications by primarily targeting the inactivation process. In a drug discovery project aiming at finding potential anticonvulsants, we have identified arbidol, originally an antiviral drug, as a potent SCB. In order to evaluate its anticonvulsant potential, we have thoroughly examined its biophysical properties as well as its effects on animal seizure models. EXPERIMENTAL APPROACH: Patch clamp recording was used to investigate the electrophysiological properties of arbidol, as well as the binding and unbinding kinetics of arbidol, carbamazepine and lacosamide...
July 9, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38982680/coptisine-exerts-anti-tumour-effects-in-triple-negative-breast-cancer-by-targeting-mitochondrial-complex-i
#38
JOURNAL ARTICLE
Yunfu Shen, You Yang, Zi Wang, Wanjun Lin, Na Feng, Meina Shi, Jiachen Liu, Wenzhe Ma
BACKGROUND AND PURPOSE: Triple-negative breast cancer (TNBC) has a poor prognosis due to limited therapeutic options. Recent studies have shown that TNBC is highly dependent on mitochondrial oxidative phosphorylation. The aim of this study was to investigate the potential of coptisine, a novel compound that inhibits the complex I of the mitochondrial electron transport chain (ETC), as a treatment for TNBC. EXPERIMENTAL APPROACH: In this study, mitochondrial metabolism in TNBC was analysed by bioinformatics...
July 9, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38982588/a-vitamin-d-based-strategy-overcomes-chemoresistance-in-prostate-cancer
#39
JOURNAL ARTICLE
Kateryna Len-Tayon, Claire Beraud, Clara Fauveau, Anna Y Belorusova, Yassmine Chebaro, Antonio Mouriño, Thierry Massfelder, Anne Chauchereau, Daniel Metzger, Natacha Rochel, Gilles Laverny
BACKGROUND AND PURPOSE: Castration-resistant prostate cancer (CRPC) is a common male malignancy that requires new therapeutic strategies due to acquired resistance to its first-line treatment, docetaxel. The benefits of vitamin D on prostate cancer (PCa) progression have been previously reported. This study aimed to investigate the effects of vitamin D on chemoresistance in CRPC. EXPERIMENTAL APPROACH: Structure function relationships of potent vitamin D analogues were determined...
July 9, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38978400/a-highly-selective-inhibitor-of-discoidin-domain-receptor-1-ddr1-in-1-protects-corneal-epithelial-cells-from-yap-acsl4-mediated-ferroptosis-in-dry-eye
#40
JOURNAL ARTICLE
Yiqin Dai, Yue Li, Jianjiang Xu, Jing Zhang
BACKGROUND AND PURPOSE: This study investigated the involvement of discoidin domain receptor (DDR) in dry eye and assessed the potential of specific DDR inhibitors as a therapeutic strategy for dry eye by exploring the underlying mechanism. EXPERIMENTAL APPROACH: Dry eye was induced in Wistar rats by applying 0.2% benzalkonium chloride (BAC), after which rats were treated topically for 7 days with DDR1-IN-1, a selective inhibitor of DDR1. Clinical manifestations of dry eye were assessed on Day-7 post-treatment...
July 8, 2024: British Journal of Pharmacology
journal
journal
25694
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.